In clinical trials, retatrutide has been administered via subcutaneous injection on a once-weekly basis, with doses escalating gradually over several weeks to improve tolerability
Disclaimer: The anti-inflammatory properties discussed are based on preclinical studies and anecdotal user feedback
So I think theres a concern here that, if you start prescribing this, for addiction that there will be a point in which when theyre no longer on the a, the medications that their cravings for cocaine or alcohol or heroin, you name it will return and thats a concern because if you have stopped using a substance as powerful as heroin for a period of time and then you end up going back to it, then your tolerance is much reduced and your risk of overdose is much, much higher
Effects of L-carnitine infusion on intralipid clearance and utilization
The submission is supported by the SURPASS-CVOT trial, which showed that Mounjaro reduced the risk of MACEincluding CV death, heart attack, or strokeby 8% compared with Trulicity (p=0.086), demonstrating noninferiority to Trulicity regarding CV risk
